Back to results
CompletedPhase 3

Evaluation of Galantamine in the Treatment of Alzheimer's Disease

NCT00000172

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Alabama, Birmingham

Birmingham, Alabama, United States

+54 additional locations

View on ClinicalTrials.gov
Evaluation of Galantamine in the Treatment of Alzheimer's Disease — TrialFind